TOP TIERMARKET NEWSWIRE
News & sentiment

ORUKA THERAPEUTICS I (ORKA) — News & AI sentiment

ORUKA THERAPEUTICS I (ORKA) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 54/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 15 sales totalling $319.0M — net selling of $319.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 54/100
Insider net (90d)
$319.0M
0 buys · 15 sells
Congress (90d)
0
0 buys · 0 sells

ORKA news in the last 24 hours, 7 days, 30 days and 90 days

How much ORKA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowORKA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days654/100ORKA headlines →
Last 90 days1451.7/100ORKA headlines →

Latest stories on ORKA

Sep 9
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Sep 3
Aug 28
Aug 24
Aug 24
Aug 21
Aug 10
Aug 10
Aug 10
Aug 10
Aug 3
Jul 10
Jul 1
Jun 24
Jun 1
May 31
May 28
May 10
Open ORKA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →